Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Market Cap

Arbutus Biopharma has a market cap or net worth of $837.56 million as of May 15, 2026. Its market cap has increased by 23.21% in one year.

• Market Cap: 837.56M
• Enterprise Value: 767.97M
• 1-Year Change: 23.21%
• Ranking: #2705
• Category: Small-Cap
• Stock Price: $4.24

Market Cap Chart

Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $837.56M, an increase of 1,663.28%. That is a compound annual growth rate of 19.15%.

Market Cap History

Date	Market Cap	% Change
May 14, 2026	859.30M	-7.11%
Dec 31, 2025	925.10M	49.31%
Dec 31, 2024	619.60M	47.81%
Dec 29, 2023	419.20M	14.98%
Dec 30, 2022	364.60M	-30.71%
Dec 31, 2021	526.20M	74.59%
Dec 31, 2020	301.40M	90.76%
Dec 31, 2019	158.00M	-25.65%
Dec 31, 2018	212.50M	-23.56%
Dec 29, 2017	278.00M	106.85%
Dec 30, 2016	134.40M	-44.65%
Dec 31, 2015	242.80M	-28.19%
Dec 31, 2014	338.10M	196.58%
Dec 31, 2013	114.00M	89.05%
Dec 31, 2012	60.30M	289.03%
Dec 30, 2011	15.50M	-68.04%
Dec 31, 2010	48.50M	2.11%
Dec 31, 2009	47.50M	-
Dec 31, 2009	47.50M	-

View and export this data all the way back to 2009. Sign Up Today.

Related Stocks

Company	Market Cap
Janux Therapeutics	878.78M
Alpha Tau Medical	869.54M
Alto Neuroscience	863.35M
Kura Oncology	859.22M
ARS Pharmaceuticals	856.96M
Theravance Biopharma	849.59M
Seaport Therapeutics	845.79M
CytomX Therapeutics	844.69M